Pathologic Stage III Gastric Cancer AJCC v8

Explore clinical trials studying Pathologic Stage III Gastric Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Pathologic Stage III Gastric Cancer AJCC v8 trial results

Active, not recruiting

Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma

NCT05041153

Conditions: Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Gastric Cancer AJCC v8, +30 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma

NCT04523818

Conditions: Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, +13 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery

NCT03997162

Conditions: Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, +15 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

NCT04111172

Conditions: Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8, +50 more
Locations: Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

NCT04501913

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +213 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study

NCT04449679

Conditions: Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8, Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage 0 Gastric Cancer AJCC v8, +98 more
Locations: Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma

NCT03395847

Conditions: Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, +22 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Pathologic Stage III Gastric Cancer AJCC v8

Pathologic Stage III Gastric Cancer AJCC v8 trial results

Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma

Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study

Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma

Related conditions